- Market Realist•3 hours ago
KKR & Co. (KKR) beat Wall Street analysts’ earnings expectations of $0.03 per share and reported EPS of $0.23 on July 26, 2016. This compares with the company's EPS of $0.88 for fiscal 2Q15.
KKR & Co. L.P. (NYSE: KKR ) indicated that India-based Gland Pharma Limited signed a definitive agreement with Shanghai Fosun Pharmaceutical (Group) Co. Ltd. under which Fosun would buy about 86% stake ...
|Bid||0.00 x 50100|
|Ask||0.00 x 49600|
|52wk Range||10.65 - 13.14|
|Day's Range||11.02 - 11.02|
|Avg Vol (3m)||62|
As of 2:08 AM EDT. Market closed.